title: Re: androgen deprivation therapy: impact on quality of life and cardiovascular health.
authors.affiliation: Department of Surgery and Cancer, Imperial College London, London, UK.
authors.forename: Syed I A
authors.initials: SI
authors.lastname: Shah
authors.forename: Fay H
authors.initials: FH
authors.lastname: Cafferty
authors.forename: Ruth E
authors.initials: RE
authors.lastname: Langley
authors.forename: Paul D
authors.initials: PD
authors.lastname: Abel
mesh_terms: D000726:Androgen Antagonists / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D016903:Drug Monitoring; D020249:Hormone Replacement Therapy; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011788:Quality of Life
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal